These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 8097719

  • 1. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    Angel I, Grosset A, Perrault G, Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1993 Apr 06; 234(2-3):137-45. PubMed ID: 8097719
    [Abstract] [Full Text] [Related]

  • 2. SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile.
    Angel I, Schoemaker H, Arbilla S, Galzin AM, Berry C, Niddam R, Pimoule C, Sevrin M, Wick A, Langer SZ.
    J Pharmacol Exp Ther; 1992 Dec 06; 263(3):1327-33. PubMed ID: 1281878
    [Abstract] [Full Text] [Related]

  • 3. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
    Berridge TL, Doxey JC, Roach AG, Smith CF.
    Eur J Pharmacol; 1992 Mar 24; 213(2):205-12. PubMed ID: 1355733
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM.
    Br J Pharmacol; 1996 Jun 24; 118(4):871-8. PubMed ID: 8799556
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.
    Görnemann T, von Wenckstern H, Kleuser B, Villalón CM, Centurión D, Jähnichen S, Pertz HH.
    Br J Pharmacol; 2007 May 24; 151(2):186-94. PubMed ID: 17375080
    [Abstract] [Full Text] [Related]

  • 6. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM, MacKinnon AC, Redfern WS, Hicks PE, Kilpatrick AT, Small C, Ramcharan M, Clague RU, Clark RD, MacFarlane CB.
    Br J Pharmacol; 1993 Feb 24; 108(2):516-25. PubMed ID: 8095420
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C, Bouysset F, Cordi AA, Laubie M, Verbeuren TJ.
    Br J Pharmacol; 1996 Feb 24; 117(3):587-593. PubMed ID: 8821553
    [Abstract] [Full Text] [Related]

  • 8. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I, Lefèvre-Borg F, Roach AG, Gomeni R, Scatton B.
    J Pharmacol Exp Ther; 1982 Oct 24; 223(1):241-50. PubMed ID: 6126583
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.
    Dabire H, Dausse JP, Mouille P, Fournier B, Cardot A, Meyer P, Schmitt H.
    Clin Exp Hypertens A; 1986 Oct 24; 8(3):387-409. PubMed ID: 2873908
    [Abstract] [Full Text] [Related]

  • 10. In vitro stimulation of insulin release by SL 84.0418, a new alpha 2-adrenoceptor antagonist.
    Jonas JC, Plant TD, Angel I, Langer SZ, Henquin JC.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):27-33. PubMed ID: 7911430
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
    Brown MJ, Harland D.
    Br J Pharmacol; 1984 Nov 11; 83(3):657-65. PubMed ID: 6150737
    [Abstract] [Full Text] [Related]

  • 12. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC, Roach AG, Smith CF.
    Br J Pharmacol; 1983 Mar 11; 78(3):489-505. PubMed ID: 6132640
    [Abstract] [Full Text] [Related]

  • 13. Antagonistic effects of S9871 or (imidazolinyl-2)-2-dihydro 2,3 benzofurane and its stereoisomers on some central and peripheral actions of alpha 2-agonists.
    Joly G, Mouillé P, Schmitt H.
    Arch Int Pharmacodyn Ther; 1985 Oct 11; 277(2):180-91. PubMed ID: 2865936
    [Abstract] [Full Text] [Related]

  • 14. The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonist.
    Halliday CA, Jones BJ, Skingle M, Walsh DM, Wise H, Tyers MB.
    Br J Pharmacol; 1991 Apr 11; 102(4):887-95. PubMed ID: 1677298
    [Abstract] [Full Text] [Related]

  • 15. Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery.
    Langer SZ, Angel I.
    J Neural Transm Suppl; 1991 Apr 11; 34():171-7. PubMed ID: 1687782
    [Abstract] [Full Text] [Related]

  • 16. In vivo demonstration of alpha-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial alpha-adrenoceptors.
    Broadley KJ, Williamson KL, Roach AG.
    J Auton Pharmacol; 1999 Feb 11; 19(1):55-63. PubMed ID: 10385270
    [Abstract] [Full Text] [Related]

  • 17. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW, Doxey JC, Walter DS, Reid JL.
    Br J Pharmacol; 1990 Aug 11; 100(4):699-704. PubMed ID: 1976400
    [Abstract] [Full Text] [Related]

  • 18. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC, Roach AG, Strachan DA, Virdee NK.
    Br J Pharmacol; 1984 Nov 11; 83(3):713-22. PubMed ID: 6150740
    [Abstract] [Full Text] [Related]

  • 19. Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
    Timmermans PB, de Jonge A, Thoolen MJ, Wilffert B, Batink H, van Zwieten PA.
    J Med Chem; 1984 Apr 11; 27(4):495-503. PubMed ID: 6142954
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
    Niddam R, Angel I, Bidet S, Langer SZ.
    J Pharmacol Exp Ther; 1990 Sep 11; 254(3):883-7. PubMed ID: 1975625
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.